Understanding how tau proteins enter brain cells and cause Alzheimer's disease
Mechanism of cell uptake for pathogenic tau seeds
This study is looking at how tau proteins, which are connected to Alzheimer's disease, move between brain cells and cause problems, and it's designed for anyone interested in understanding more about how these proteins affect brain health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-11061332 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which tau proteins, which are linked to Alzheimer's and other neurodegenerative diseases, enter brain cells and contribute to disease progression. The study focuses on how abnormal tau aggregates can exit one cell and enter neighboring cells, potentially corrupting healthy tau proteins. Using a mouse model, researchers will explore the role of specific enzymes that modify cell surface proteins, which may facilitate the entry of tau aggregates into cells. This work aims to uncover the pathways involved in tau uptake and their implications for neurodegeneration.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for or diagnosed with Alzheimer's disease or related neurodegenerative conditions.
Not a fit: Patients with neurodegenerative diseases not associated with tau protein aggregation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for preventing or treating Alzheimer's disease by targeting the mechanisms of tau protein aggregation and cell entry.
How similar studies have performed: Previous research has shown promising results in understanding tau protein dynamics, but this specific approach to studying tau uptake mechanisms is relatively novel.
Where this research is happening
Dallas, United States
- Ut Southwestern Medical Center — Dallas, United States (Active)
Researchers
- Principal investigator: Diamond, Marc I — Ut Southwestern Medical Center
- Study coordinator: Diamond, Marc I
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.